StonvexLoading…
StonvexStonvexStonvexCore line items from CHH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2024 2024-09-30 | Q2 2024 2024-06-30 | Q1 2024 2024-03-31 | Annual 2023 2023-12-31 |
|---|---|---|---|---|
Revenue | $1.20B | $767.11M | $331.95M | $1.54B |
Operating Income | $344.55M | $192.77M | $60.15M | $375.03M |
Net Income | $223.86M | $87.14M | $31.01M | $258.51M |
EPS (Diluted) | $4.61 | $2.41 | $0.62 | $5.07 |
Total Assets | $2.54B | $2.52B | $2.48B | $2.39B |
Total Liabilities | $2.64B | $2.67B | $2.47B | $2.36B |
Cash & Equivalents | $58.56M | $60.41M | $42.11M | $26.75M |
Free Cash Flow OCF − CapEx | $155.30M | $62.74M | $-23.83M | $227.99M |
Shares Outstanding | 46.96M | 47.35M | 49.28M | 49.53M |